Kymera Therapeutics, Inc. · NASDAQ:KYMR

Booth Bruce sold 9,494 Kymera Therapeutics, Inc. shares (Form 4)

Traded Apr 14 to Apr 15, 2026 · Filed Apr 16, 2026

From Apr 14 to Apr 15, 2026, Booth Bruce (Director) sold 9,494 Kymera Therapeutics, Inc. shares at an average US$90.01 for US$855K under a trading plan, leaving 674,956 shares. Filed Apr 16, 2026 (Form 4).

Sold
9,494 shares
Price
US$90.01 average (US$89.95 to US$90.10)
Value
US$855K
Holding after
674,956 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 14, 2026Common StockOption exercise4,159US$14.184,159Direct
Apr 14, 2026Common StockSale4,159US$89.970Direct
Apr 15, 2026Common StockOption exercise2,200US$14.182,200Direct
Apr 15, 2026Common StockSale2,200US$89.950Direct
Apr 15, 2026Common StockSale2,750US$90.103,899,917Indirect
Apr 15, 2026Common StockSale385US$90.10674,956Indirect

Source

View original at SEC

Related